|
Daniel's Biotech Briefing
Cyllene Therapeutics raises €33 million for HSV gene therapy research, Genentech teams with Astex on breast cancer drugs, and microbiome studies push anaerobic workflows.
The top 10 stories from Mon Jul 6, 2026 07:07 AM to Tue Jul 7, 2026 07:08 AM
Generated July 7, 2026 at 7:08 AM
|
|
|
#1 Bayer Foundation Women Entrepreneurs Award: From AI Diagnostics to Circular Food Tech, 15 Women Are Transforming Health and Food Systems Worldwide Published 2026-07-07 On July 7, 2026, the Bayer Foundation Women Entrepreneurs Award selected 15 women from Latin America, Africa, and Asia for work addressing global healthcare and food security. Covered by: prnewswire.com |
#2 New sa‑mRNA and LNP Platform to Support Korea’s Hantavirus Vaccine Initiative Published 2026-07-07 Korea University’s Vaccine Innovation Center will lead a government-supported project to develop next-generation hantavirus vaccines using self-amplifying mRNA and LNP platforms. Covered by: genengnews.com |
#3 With $1.1B Myricx buy, Novartis takes plunge into ADCs Published 2026-07-07 Novartis agreed to acquire preclinical U.K. ADC company Myricx in a deal reported at $1.1 billion, expanding its pipeline with novel payloads. Covered by: biocentury.com, endpoints.news |
#4 Genentech Turns To Astex To Shore Up Breast Cancer Pipeline Published 2026-07-06 Astex and Genentech signed a deal to develop breast cancer drugs. Covered by: insights.citeline.com |
#5 French gene therapy biotech gets €33M to follow Krystal's blueprint Published 2026-07-07 A small French-US biotech, Cyllene Therapeutics, raised about €33 million to fund research on HSV-based gene therapy in a different therapeutic area than Krystal Biotech. Covered by: endpoints.news |
#6 Aureka Releases OpenDDE, an Open-Source Drug Discovery Engine Designed to Accelerate AI-Driven Therapeutic Discovery Published 2026-07-07 Aureka announced the July 6, 2026 release of OpenDDE, an open-source drug discovery engine using an all-atom biomolecular foundation model with co-folding to support scalable therapeutic discovery. Covered by: prnewswire.com |
#7 Active Motif Announces Exclusive Global Distribution Agreement with Arima Genomics for Advanced 3D Genomics Solutions Published 2026-07-06 Active Motif announced an exclusive global distribution agreement with Arima Genomics to expand Active Motif’s research genomics portfolio and support Arima’s clinical diagnostics focus. Covered by: prnewswire.com |
#8 Biopharma IPO Fundraising And Returns Soar In Q2 Published 2026-07-06 Western exchanges saw biopharma IPO fundraising rise from $1.8 billion in Q1 to $3.8 billion in Q2. Covered by: insights.citeline.com |
#9 Unlocking Microbiome Function with Anaerobic Workflows and Metabolic Phenotyping Published 2026-07-06 The article argues that microbiome research needs anaerobic-preserving workflows and metabolic phenotyping to measure active microbial functions, since sequencing shows presence but not gene expression or real-world activity. Covered by: genengnews.com |
#10 CurifyLabs Raises $14M Series A to Power the Future of Personalized Medicine Published 2026-07-06 CurifyLabs announced the closing of a $14 million Series A investment from Sandwater, HealthCap, and Tesi to support supply chain, customer support, and R&D. Covered by: prnewswire.com, prnewswire.com |
